CLASS II Device recall · Reported 16 Oct 2019 · FDA Enforcement Report

Clinical Chemistry, ABX Pentra Lipase CP, ABX Pentra 400/Pentrac400 recalled

Horiba Instruments is recalling Clinical Chemistry, ABX Pentra Lipase CP, ABX Pentra 400/Pentrac400, distributed in 40 states. The recall was initiated on 30 Oct 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll Lots; All Software versions
Quantity recalled1539 Chemistry Analyzers

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0119-2020
FDA event ID
83701
Recalling firm
Horiba Instruments, Irvine, CA
Classification
Class II
Status
Terminated
Recall initiated
30 Oct 2018
FDA classified
10 Oct 2019
Reported
16 Oct 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

30 Oct 2018Recall initiated by company
10 Oct 2019Classified by FDA+345 days
16 Oct 2019Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for chemical analyzer to report abnormal results due to an interference with triglycerides CP and Cholesterol CP. An over estimation of the lipase concentration could be observed and a patient result could be declared abnormal by the instrument due to these interferences instead of normal result < 38 U/L (or < reference value used in your laboratory).

Product as listed by the FDA

Clinical Chemistry, ABX Pentra Lipase CP, ABX Pentra 400/Pentrac400, REF: A11A01631, Model/Part # 1220001631, UDI # 03610230004944

Where it was distributed

US: AL, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY

AlabamaArizonaCaliforniaColoradoConnecticutFloridaGeorgiaIowaIdahoIllinoisKansasKentuckyLouisianaMassachusettsMarylandMichiganMinnesotaMissouriMississippiMontana

Questions about this recall

Why was it recalled?

Potential for chemical analyzer to report abnormal results due to an interference with triglycerides CP and Cholesterol CP. An over estimation of the lipase concentration could be observed and a patient result could be declared abnormal by the instrument due to these interferences instead of normal result < 38 U/L (or < reference value used in your laboratory).

Which lots are affected?

All Lots; All Software versions

Where was it sold?

US: AL, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Horiba Instruments

All 28

Other Other Medical Devices recalls

All 13,778